First Psilocybin-Assisted Addiction Recovery Program in U.S. Opens in Oregon
Oregon pioneers the first Psilocybin-Assisted Addiction Recovery Program in the United States.
Oregon pioneers the first Psilocybin-Assisted Addiction Recovery Program in the United States.
Ever since experiencing the transformative effects of cannabis and psilocybin, Russell has become an unwavering champion of plant medicine.
Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.
In this episode, Arrowyn speaks on how psychedelics are integrated into recovery and addiction, how community can profoundly impact those in recovery, and how we can assist those who are in need of psychedelic therapy but may not have access.
A new study indicates that psilocybin-assisted therapy may reduce heavy drinking in patients with alcohol use disorder, with up to half of patients quitting altogether
Researchers are exploring the therapeutic potential of ayahuasca, a visionary brew containing DMT. Here’s everything you need to know.
This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!
Those caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not face jail time when the regulations go into effect.
Researchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred reduced risk of past-year opioid dependence and abuse.
This month’s “Spotlight in Focus” features candid conversation with an opioid addict, and the director writes how psychedelic therapy can help.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.